0

Dry Eye Syndrome Drugs Market by Product and Geography - Forecast and Analysis 2021-2025

  • Published: Jan 2021
  • Pages: 120
  • SKU: IRTNTR46644
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The dry eye syndrome drugs market size has the potential to grow by USD 2.08 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 6.81%. 

This report provides a detailed analysis of the market by product (OTC drugs and prescription drugs), geography (Asia, Europe, North America, and ROW), and key vendors. 

Market Overview

Dry-Eye-Syndrome-Drugs-Market-Market-Size-2020-2025

Browse TOC and LoE with selected illustrations and example pages of Dry Eye Syndrome Drugs Market Request a FREE sample now!

Market Competitive Analysis

The report analyzes the market’s competitive landscape and offers information on several market vendors, including: 

 

  • AbbVie Inc.
  • Akorn Inc.
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Johnson & Johnson
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Prestige Consumer Healthcare Inc.
  • Santen Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.

 

The dry eye syndrome drugs market is fragmented and the vendors are deploying growth strategies such as focusing on product R&D to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

The market players also significantly leverage external market drivers such as changing lifestyles and rising cases of diseases contributing to dry eye syndrome to achieve growth opportunities. However, factors such as the presence of strong substitutes will challenge the growth of the market participants. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the dry eye syndrome drugs market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

This dry eye syndrome drugs market analysis report also provides detailed information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of their future growth opportunities. 

Dry Eye Syndrome Drugs Market: Key Drivers and Trends

  • The changing lifestyle and rising cases of diseases contributing to dry eye syndrome will be one of the primary growth factors for the dry eye syndrome drugs market. 
  • Dry eye syndrome is gaining prominence due to the changing lifestyles, consumption of specified medicines, and increased rate of diseases.
  • Autoimmune diseases, genetic factors, environmental conditions, and routine practices such as extended usage of contact lenses and prolonged computer usage also cause dry eye syndrome. 
  • The increasing prevalence of dry eye syndrome will fuel the demand for dry eye syndrome drugs during the forecast period.
  • The advancements in diagnostic techniques for dry eye syndrome is identified to be one of the key trends contributing to the growth of the dry eye syndrome treatment market.
  • Diagnostic technology advancements improve the disease diagnostic rate and cater efficiently to the ophthalmic and retinal disorders.
  • Advanced diagnostic approaches aid in diagnosing the disease in asymptomatic dry-eye patients.
  • Diagnostic approaches such as rapid Pathogen Screening and LipiView (TearScience) are used by physicians to ease the diagnostic process.

Grab your Free Sample now to unlock further information on other key market drivers

 

Dry Eye Syndrome Drugs Market: Segmentation by Geography

Dry-Eye-Syndrome-Drugs-Market-Market-Share-by-Region-2020-2025

For more insights on the market share of various regions Request for a FREE sample now!

37% of the market’s growth will originate from North America during the forecast period. The US is a key market for dry eye syndrome drugs in North America. However, market growth in North America will be slower than the growth of the market in other regions.

The entry of new prescription-based products is one of the prime factors that will facilitate the dry eye syndrome drugs market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report. 

Dry Eye Syndrome Drugs Market: Segmentation by Product

Dry-Eye-Syndrome-Drugs-Market-Market-Share-by-Product-2020-2025

Request for a FREE sample and Get more information on the market contribution of various segments

OTC drugs are available in the form of eye drops, ointments, and gels. The increase in product launches is ensuring the easy availability of preservative-free eye drops, thereby driving the revenue growth in the OTC drugs segment. The entry of new OTC’s with a longer period of relief and minimum side effects are expected to gain significant adoption globally, thereby driving the dry eye syndrome drugs market during the forecast period. However, the dry eye syndrome drugs market share growth by the OTC drugs segment will be slower than the prescription drugs segment.    

This report provides an accurate prediction of the contribution of all the segments to the growth of the dry eye syndrome drugs market size. Fetch actionable market insights on post COVID-19 impact on each segment.   

 

Event-Tickets-Market-Report

Request for a FREE sample

Dry Eye Syndrome Drugs Market: Key Highlights of the Report for 2021-2025

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive dry eye syndrome drugs market growth during the next five years
  • Precise estimation of the dry eye syndrome drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the dry eye syndrome drugs industry across Asia, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of dry eye syndrome drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Executive Summary

    Market Landscape

    • Market ecosystem
    • Market characteristics
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Five forces summary
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Product

    • Market segments
    • Comparison by Product
    • OTC drugs - Market size and forecast 2020-2025
    • Prescription drugs - Market size and forecast 2020-2025
    • Market opportunity by Product

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2020-2025
      • Europe - Market size and forecast 2020-2025
      • Asia - Market size and forecast 2020-2025
      • ROW - Market size and forecast 2020-2025
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Vendor Landscape
      • Landscape disruption
      • Competitive scenario

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • AbbVie Inc.
      • Akorn Inc.
      • Alcon Inc.
      • Bausch Health Companies Inc.
      • Johnson & Johnson
      • Novartis AG
      • Otsuka Holdings Co. Ltd.
      • Prestige Consumer Healthcare Inc.
      • Santen Pharmaceutical Co. Ltd.
      • Sun Pharmaceutical Industries Ltd.

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your sample now!
      Dry Eye Syndrome Drugs market growth will increase by $2076.79 million during 2020-2025.
      The dry eye syndrome drugs market is expected to grow at a CAGR of 6.81% during 2020-2025.
      Technavio has segmented the dry eye syndrome drugs market by product (OTC drugs and Prescription drugs) and geographic (North America, Europe, Asia, and ROW).
      AbbVie Inc., Akorn Inc., Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson, Novartis AG, Otsuka Holdings Co. Ltd., Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd. are a few of the key vendors in the dry eye syndrome drugs market.
      North America will register the highest growth rate of 37.35% among the other regions. Therefore, the dry eye syndrome drugs market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      The key factors driving the dry eye syndrome drugs market growth are:
      • Growing geriatric population
      The dry eye syndrome drugs market vendors should focus on grabbing business opportunities from the otc drugs segment as it accounted for the largest market share in the base year.
      • What are the key global market and the regional market share?
      • What are the revenue-generating key market segments?
      • What are the key factors driving and challenging this market’s growth?
      • Who are the key market vendors and their growth strategies?
      • What are the latest trends influencing the growth of this market?
      • What are the variables influencing the market growth in the primary regions?
      • What are the factors influencing the growth of the parent market?
      • Off-the-shelf research reports
      • Reports can be tailored to meet the customer's needs
      • Trusted by more than 100 fortune 500 organizations
      • Information about the market's key drivers, trends, and challenges
      • Parent market analysis
      • Every week, 50,000 people visit our subscription platform
      • Detailed vendors report with competitive landscape
      • Covid-19 impact and recovery analysis
      • Data on revenue-generating market segments
      • Details on the market shares of various regions
      • Five-force market analysis

      Certified ISO 9001 : 2015

      We are ISO recognized

      We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

      We are GDPR and CCPA compliant

      We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

      Safe and Secure SSL Encrypted
      Technavio

      info
      close
      • Single:

        One user only.
        Quick & easy download option

      • Enterprise:

        Unlimited user access (Within your organization)
        Complimentary Customization Included

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Customized Report as per your Business Needs

      • Our analysts will work directly with you and understand your needs
      • Get data on specified regions or segments, competitor and Vendors
      • Data will be formatted and presented as per your requirements
      • We offer $1000 worth of FREE customization at the time of purchase

      Let us help you make report more suited to your requirements.

      • Get a competitive breakdown as per your niche industry
      • Customize the data with various metrics that meet your business prerequisite
      • Understand Revenue Sources, Customers and many more
      • Details on Market Share
      • These customizations are done in a short amount of time by our analysts and industry experts
      Technavio
      Enquire Before Buying
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>